Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial

NCT: NCT06249776 · COMPLETED

NCT IDNCT06249776
StatusCOMPLETED
Start Date2024-02-09
Completion2026-04-14

Brief Summary

The study aims to evaluate the safety and efficacy of the Supernova stent retriever device, developed by Gravity Medical Technology, for treating acute ischemic stroke. The device is used to remove blood clots and restore blood flow to the brain .

Frequently Asked Questions

What is Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial?

Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial is a clinical trial registered under NCT06249776. Current status: COMPLETED.

What is the status of NCT06249776?

The current status of NCT06249776 (Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial) is: COMPLETED.

When did Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial start?

Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial started on 2024-02-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.